APA (7th ed.) Citation

Kunkel, J. B., Holle, S. L. D., Hassager, C., Pecini, R., Wiberg, S., Palm, P., . . . Søholm, H. Interleukin-6 receptor antibodies (tocilizumab) in acute myocardial infarction with intermediate to high risk of cardiogenic shock development (DOBERMANN-T): Study protocol for a double-blinded, placebo-controlled, single-center, randomized clinical trial. BMC.

Chicago Style (17th ed.) Citation

Kunkel, Joakim Bo, et al. Interleukin-6 Receptor Antibodies (tocilizumab) in Acute Myocardial Infarction with Intermediate to High Risk of Cardiogenic Shock Development (DOBERMANN-T): Study Protocol for a Double-blinded, Placebo-controlled, Single-center, Randomized Clinical Trial. BMC.

MLA (9th ed.) Citation

Kunkel, Joakim Bo, et al. Interleukin-6 Receptor Antibodies (tocilizumab) in Acute Myocardial Infarction with Intermediate to High Risk of Cardiogenic Shock Development (DOBERMANN-T): Study Protocol for a Double-blinded, Placebo-controlled, Single-center, Randomized Clinical Trial. BMC.